Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non‐muscle‐invasive bladder cancer: A retrospective multicenter study
Takuma Sato(Tohoku University), Akihiro Ito(Tohoku University), Takeshi Sano(Tokushima University), Shinichi Yamashita, Kazuhiko Orikasa(Sendai Shakai Hoken Hospital), Atsushi Kyan(Sendai Shakai Hoken Hospital), Koji Mitsuzuka(Pacific Northwest Diabetes Research Institute), Yoichi Arai(Japan Atomic Energy Agency), Takaki Tanaka(Tohoku University), Hideo Saitô(Tohoku University), Yoshihiro Ikeda(Kyoto Medical Center), Shōzō Ōta(Akita Red Cross Hospital), Takashi Kobayashi(Kyoto University), Satoru Tokuyama(Miyagi Prefectural Hospital Organization), Sadafumi Kawamura(Miyagi Prefectural Hospital Organization)
Cited by 8
Related Papers
Prospective Randomized Phase II Trial of a Single Early Intravesical Instillation of Pirarubicin (THP) in the Prevention of Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma: The THP Monotherapy Study Group Trial
|Journal of Clinical Oncology|2013|253
Molecular Cloning and Characterization of a Plasma Membrane-associated Sialidase Specific for Gangliosides
|Journal of Biological Chemistry|1999|182
ANATOMICAL ANALYSIS OF THE NEUROVASCULAR BUNDLE SUPPLYING PENILE CAVERNOUS TISSUE TO ENSURE A RELIABLE NERVE GRAFT AFTER RADICAL PROSTATECTOMY
|The Journal of Urology|2004|159
Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic Cancer
|The Journal of Urology|1990|122
Plasma Membrane-associated Sialidase Is Up-regulated in Renal Cell Carcinoma and Promotes Interleukin-6-induced Apoptosis Suppression and Cell Motility
|Journal of Biological Chemistry|2006|116